111 related articles for article (PubMed ID: 8031472)
1. Complement C3 deficiency: human, animal, and experimental models.
Singer L; Colten HR; Wetsel RA
Pathobiology; 1994; 62(1):14-28. PubMed ID: 8031472
[TBL] [Abstract][Full Text] [Related]
2. An inherited deficiency of the third component of complement, C3, in guinea pigs.
Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
[TBL] [Abstract][Full Text] [Related]
3. Hereditary deficiency of C3 in animals and humans.
Botto M; Walport MJ
Int Rev Immunol; 1993; 10(1):37-50. PubMed ID: 8340676
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency.
Ameratunga R; Winkelstein JA; Brody L; Binns M; Cork LC; Colombani P; Valle D
J Immunol; 1998 Mar; 160(6):2824-30. PubMed ID: 9510185
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of an inherited deficiency of the third component of complement in Brittany spaniel dogs.
Johnson JP; McLean RH; Cork LC; Winkelstein JA
Am J Med Genet; 1986 Nov; 25(3):557-62. PubMed ID: 3789016
[TBL] [Abstract][Full Text] [Related]
6. Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion.
Singer L; Whitehead WT; Akama H; Katz Y; Fishelson Z; Wetsel RA
J Biol Chem; 1994 Nov; 269(45):28494-9. PubMed ID: 7961791
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.
S Reis E; Falcão DA; Isaac L
Scand J Immunol; 2006 Mar; 63(3):155-68. PubMed ID: 16499568
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of complement C3 deficiency in guinea pigs.
Auerbach HS; Burger R; Dodds A; Colten HR
J Clin Invest; 1990 Jul; 86(1):96-106. PubMed ID: 1973176
[TBL] [Abstract][Full Text] [Related]
9. C3 deficiencies.
Bitter-Suermann D; Burger R
Curr Top Microbiol Immunol; 1990; 153():223-33. PubMed ID: 2404696
[No Abstract] [Full Text] [Related]
10. Inherited complement C3 deficiency: reduced C3 mRNA and protein levels in a Laotian kindred.
Singer L; Van Hee ML; Lokki ML; Kramer J; Borzy MS; Wetsel RA
Clin Immunol Immunopathol; 1996 Dec; 81(3):244-52. PubMed ID: 8938101
[TBL] [Abstract][Full Text] [Related]
11. Animal models for complement deficiencies.
Frank MM
J Clin Immunol; 1995 Nov; 15(6 Suppl):113S-121S. PubMed ID: 8613484
[TBL] [Abstract][Full Text] [Related]
12. Complement deficiency promotes cutaneous wound healing in mice.
Rafail S; Kourtzelis I; Foukas PG; Markiewski MM; DeAngelis RA; Guariento M; Ricklin D; Grice EA; Lambris JD
J Immunol; 2015 Feb; 194(3):1285-91. PubMed ID: 25548229
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the murine gene coding for the third complement component (C3).
Pekna M; Hietala MA; Rosklint T; Betsholtz C; Pekny M
Scand J Immunol; 1998 Jan; 47(1):25-9. PubMed ID: 9467654
[TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis in cobra venom factor-treated and C4-deficient guinea pigs.
Morariu MA; Dalmasso AP
Ann Neurol; 1978 Nov; 4(5):427-30. PubMed ID: 83812
[TBL] [Abstract][Full Text] [Related]
15. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
[TBL] [Abstract][Full Text] [Related]
16. The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency.
Kida M; Fujioka H; Kosaka Y; Hayashi K; Sakiyama Y; Ariga T
Blood Cells Mol Dis; 2008; 40(3):410-3. PubMed ID: 18201916
[TBL] [Abstract][Full Text] [Related]
17. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
18. Simple method to distinguish between primary and secondary C3 deficiencies.
Pereira de Carvalho Florido M; Ferreira de Paula P; Isaac L
Clin Diagn Lab Immunol; 2003 Mar; 10(2):216-20. PubMed ID: 12626445
[TBL] [Abstract][Full Text] [Related]
19. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs.
Böttger EC; Hoffmann T; Metzger S; Hadding U; Bitter-Suermann D
J Immunol; 1986 Aug; 137(4):1280-5. PubMed ID: 2942603
[TBL] [Abstract][Full Text] [Related]
20. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]